Literature DB >> 24234432

Successful treatment of acquired pure red cell aplasia with oral corticosteroids in a patient with B-cell CLL.

Pramila Dharmshaktu1, Naresh Gupta, Dinesh Kumar Dhanwal.   

Abstract

We present the case of a 57-year-old male patient diagnosed with chronic lymphoid leukaemia (CLL) B-cell type along with moderate anaemia. On follow-up investigations the aetiology of anaemia turned out to be pure red cell aplasia (PRCA) on trephine bone biopsy with an elevated serum erythropoietin level. The patient received blood transfusion support. He showed remarkable improvement on oral corticosteroids (prednisolone 60 mg/daily dose) with no further requirement of blood transfusion over next 3 months. However, when the dose of steroid was tapered down to 10 mg/day, the anaemia reappeared. An increase in the dose of steroid brought the haemoglobin level back to normal. Anaemia in CLL can be due to many reasons, of which PRCA is an uncommon association occurring in only around 1% of patients with CLL and usually refractory to the conventional treatment with steroids. This PRCA secondary to CLL is considered to be immune in origin and a response to combination of immunosuppressive therapy such as steroids, cyclosporine, rituximab is anticipated. Our case responded completely to oral steroids alone.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24234432      PMCID: PMC3830188          DOI: 10.1136/bcr-2013-201027

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Pure red cell aplasia.

Authors:  P Fisch; R Handgretinger; H E Schaefer
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

2.  Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia.

Authors:  Hassan Ghazal
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

Review 3.  Acquired pure red cell aplasia.

Authors:  S S Ammus; A A Yunis
Journal:  Am J Hematol       Date:  1987-03       Impact factor: 10.047

4.  Pure red-cell aplasia in patients with chronic lymphocytic leukemia.

Authors:  G Chikkappa; M H Zarrabi; M F Tsan
Journal:  Medicine (Baltimore)       Date:  1986-09       Impact factor: 1.889

Review 5.  Autoimmune complications in chronic lymphocytic leukaemia (CLL).

Authors:  Clive S Zent; Neil E Kay
Journal:  Best Pract Res Clin Haematol       Date:  2010-03       Impact factor: 3.020

Review 6.  Diagnosis and treatment of pure red cell aplasia.

Authors:  S B Krantz
Journal:  Med Clin North Am       Date:  1976-09       Impact factor: 5.456

7.  Thymomas associated with pure red cell aplasia. Histologic and follow-up studies.

Authors:  A Masaoka; T Hashimoto; K Shibata; Y Yamakawa; K Nakamae; M Iizuka
Journal:  Cancer       Date:  1989-11-01       Impact factor: 6.860

Review 8.  Diamond-Blackfan anemia.

Authors:  T N Willig; H Gazda; C A Sieff
Journal:  Curr Opin Hematol       Date:  2000-03       Impact factor: 3.284

Review 9.  Monoclonal antibodies in the treatment of autoimmune cytopenias.

Authors:  Tadeusz Robak
Journal:  Eur J Haematol       Date:  2004-02       Impact factor: 2.997

10.  Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H).

Authors:  Xiuqing Ru; Howard A Liebman
Journal:  Br J Haematol       Date:  2003-10       Impact factor: 6.998

View more
  1 in total

Review 1.  A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.

Authors:  Mazie Tsang; Sameer A Parikh
Journal:  Curr Hematol Malig Rep       Date:  2017-02       Impact factor: 3.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.